RapidAI, a health tech company specializing in imaging analysis software, announced it received FDA 510(k) clearance for its Rapid RV/LV product that aims to speed up the pulmonary embolism triage and care process.
Rapid RV/LV analyzes Computerized Tomography Pulmonary Angiograms and calculates the ratio between the right ventricle and left ventricle after a scan. The difference in measurement...
RapidAI, a health tech company that specializes in stroke imaging analysis, announced Tuesday it had received FDA 510(k) clearance for its product that aims to identify potential cases of central pulmonary embolism and alert providers.
The Rapid PE Triage & Notification tool analyzes CT pulmonary angiogram (CPTA) images and alerts care teams when it finds a suspected case, so providers can...
Interest in digital health is now sprouting up all over DC, from the president’s announcement of a new AI task force to FDA Commissioner’s shout out to digital health in his budget request.
In fact, the FDA is turning to developers in the digital health space to help solve some of the country’s most difficult problems. In May, the agency announced an innovation challenge aimed at tackling the...
Machine learning helps docs view the brain. Automated cerebrovascular imaging company iSchemaView has just released its latest product Rapid Aspect, a digital imaging tool that helps clinicians assess early signs of brain ischemia in stroke patients. The technology will automatically generate a standardized score for physicians based on machine learning algorithms. The product is designed to...
Cerebrovasular imaging company iSchemaView has received the FDA nod for its latest product the RAPID CTA, a 3D imaging platform for computed tomogrpahy angiography (CTA).
“Our goal is to provide healthcare professionals around the world with the most comprehensive and intuitive suite of imaging solutions possible,” Don Listwin, CEO of iSchemaView, said in a statement. “With new FDA approval and...
